SEKERDAG, E. Et Al. 2017. A potential non-invasive glioblastoma treatment: Nose-to-brain delivery of farnesylthiosalicylic acid incorporated hybrid nanoparticles. JOURNAL OF CONTROLLED RELEASE , vol.261 , 187-198.

SEKERDAG, E., Lule, S., PEHLIVAN, S. B., Ozturk, N., KARA, A., KAFFASHI, A., ... VURAL, İ.(2017). A potential non-invasive glioblastoma treatment: Nose-to-brain delivery of farnesylthiosalicylic acid incorporated hybrid nanoparticles. JOURNAL OF CONTROLLED RELEASE , vol.261, 187-198.

SEKERDAG, MELİKE Et Al. "A potential non-invasive glioblastoma treatment: Nose-to-brain delivery of farnesylthiosalicylic acid incorporated hybrid nanoparticles," JOURNAL OF CONTROLLED RELEASE , vol.261, 187-198, 2017

SEKERDAG, MELİKE M. Et Al. "A potential non-invasive glioblastoma treatment: Nose-to-brain delivery of farnesylthiosalicylic acid incorporated hybrid nanoparticles." JOURNAL OF CONTROLLED RELEASE , vol.261, pp.187-198, 2017

SEKERDAG, E. Et Al. (2017) . "A potential non-invasive glioblastoma treatment: Nose-to-brain delivery of farnesylthiosalicylic acid incorporated hybrid nanoparticles." JOURNAL OF CONTROLLED RELEASE , vol.261, pp.187-198.

@article{article, author={MELİKE MUT AŞKUN Et Al. }, title={A potential non-invasive glioblastoma treatment: Nose-to-brain delivery of farnesylthiosalicylic acid incorporated hybrid nanoparticles}, journal={JOURNAL OF CONTROLLED RELEASE}, year=2017, pages={187-198} }